Myriad Genetics (MYGN) Cash & Equivalents Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -2.23% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -8.24% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 21.66% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 15.43% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 9.23% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 39.74% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -10.00% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -12.05% |
| 10 | Myriad Genetics | 414.15 Mn | 289.75 Mn | 137.60 Mn | 32.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.40% |
| Dec 31, 2025 | 38.02% |
| Sep 30, 2025 | 10.18% |
| Jun 30, 2025 | -10.62% |
| Mar 31, 2025 | -17.62% |
| Dec 31, 2024 | -26.45% |
| Sep 30, 2024 | -30.31% |
| Jun 30, 2024 | -7.93% |
| Mar 31, 2024 | -13.34% |
| Dec 31, 2023 | 4.13% |
| Sep 30, 2023 | -13.71% |
| Jun 30, 2023 | -14.37% |
| Mar 31, 2023 | -23.77% |
| Dec 31, 2022 | -11.18% |
| Sep 30, 2022 | 6.53% |
| Jun 30, 2022 | 3.79% |
| Mar 31, 2022 | 24.59% |
| Dec 31, 2021 | 41.63% |
| Sep 30, 2021 | 46.81% |
| Jun 30, 2021 | 2.21% |